The stock is an excellent all-around performer, with its IBD Composite Rating coming in at a perfect 99.
Wall Street expects earnings performance to continuing to improve, with full-year EPS seen rising 90% in fiscal 2025 before posting still-impressive growth of 31% next year. This is in excess of the 25% growth levels sought by investors following The IBD Methodology.
As with Netflix, Tariffs are not especially relevant for Spotify, while the service is recession resistant.
https://www.investors.com/research/best-stocks-to-buy-now/